Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/37568
Title: Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER)
Authors: Walker, Simon
Asaria, Miqdad
Manca, Andrea
Palmer, Stephen
Gale, Chris P.
Shah, Anoop Dinesh
Abrams, Keith R.
Crowther, Michael
Timmis, Adam
Hemingway, Harry
Sculpher, Mark
First Published: 20-Jan-2016
Publisher: Oxford University Press on behalf of the European Society of Cardiology
Citation: European Heart Journal, 2016, 2 (2), pp. 125-140
Abstract: AIMS: To examine long-term healthcare utilization and costs of patients with stable coronary artery disease (SCAD). METHODS AND RESULTS: Linked cohort study of 94 966 patients with SCAD in England, 1 January 2001 to 31 March 2010, identified from primary care, secondary care, disease, and death registries. Resource use and costs, and cost predictors by time and 5-year cardiovascular disease (CVD) risk profile were estimated using generalized linear models. Coronary heart disease hospitalizations were 20.5% in the first year and 66% in the year following a non-fatal (myocardial infarction, ischaemic or haemorrhagic stroke) event. Mean healthcare costs were £3133 per patient in the first year and £10 377 in the year following a non-fatal event. First-year predictors of cost included sex (mean cost £549 lower in females), SCAD diagnosis (non-ST-elevation myocardial infarction cost £656 more than stable angina), and co-morbidities (heart failure cost £657 more per patient). Compared with lower risk patients (5-year CVD risk 3.5%), those of higher risk (5-year CVD risk 44.2%) had higher 5-year costs (£23 393 vs. £9335) and lower lifetime costs (£43 020 vs. £116 888). CONCLUSION: Patients with SCAD incur substantial healthcare utilization and costs, which varies and may be predicted by 5-year CVD risk profile. Higher risk patients have higher initial but lower lifetime costs than lower risk patients as a result of shorter life expectancy. Improved cardiovascular survivorship among an ageing CVD population is likely to require stratified care in anticipation of the burgeoning demand.
DOI Link: 10.1093/ehjqcco/qcw003
ISSN: 2058-5225
eISSN: 1522-9645
Links: http://ehjqcco.oxfordjournals.org/content/2/2/125
http://hdl.handle.net/2381/37568
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © The Author(s) 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Appears in Collections:Published Articles, Dept. of Health Sciences



Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.